Aliases & Classifications for Ischemic Heart Disease

MalaCards integrated aliases for Ischemic Heart Disease:

Name: Ischemic Heart Disease 38
Coronary Arteriosclerosis 69
Myocardial Ischemia 69
Ihd 45

Classifications:



External Ids:

ICD10 33 I20-I25

Summaries for Ischemic Heart Disease

MalaCards based summary : Ischemic Heart Disease, also known as coronary arteriosclerosis, is related to coronary artery disease and kawasaki disease, and has symptoms including angina pectoris and other and unspecified angina pectoris. An important gene associated with Ischemic Heart Disease is NOS3 (Nitric Oxide Synthase 3). The drugs Olmesartan and Everolimus have been mentioned in the context of this disorder. Affiliated tissues include Limb and Bone.

Related Diseases for Ischemic Heart Disease

Diseases related to Ischemic Heart Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 99)
id Related Disease Score Top Affiliating Genes
1 coronary artery disease 11.1
2 kawasaki disease 11.1
3 heart disease 11.1
4 sick sinus syndrome 10.8
5 myocardial infarction 10.2
6 endotheliitis 10.2
7 atherosclerosis 10.1
8 ischemia 10.1
9 breast cancer 10.1
10 cardiomyopathy 10.0
11 rheumatoid arthritis 10.0
12 arthritis 10.0
13 cerebrovascular disease 10.0
14 influenza 10.0
15 obesity 9.9
16 dilated cardiomyopathy 9.9
17 sleep apnea 9.9
18 sudden cardiac death 9.9
19 artery disease 9.9
20 obstructive sleep apnea 9.9
21 arteriosclerosis 9.9
22 congestive heart failure 9.8
23 atrial fibrillation 9.8
24 pneumonia 9.8
25 chronic angina 9.7
26 bronchogenic cyst 9.7
27 osteoporosis 9.7
28 hepatitis 9.7
29 chlamydia 9.7
30 periodontitis 9.7
31 aneurysm 9.7
32 lung disease 9.7
33 hypoxia 9.7
34 peripheral vascular disease 9.7
35 prostatitis 9.7
36 coronary stenosis 9.7
37 syncope 9.7
38 angina pectoris 9.7
39 vascular disease 9.7
40 arteriosclerosis obliterans 9.7
41 systolic heart failure 9.7
42 acute myocardial infarction 9.7
43 hyperuricemia 9.7
44 mucositis 9.6
45 protein s deficiency 9.6
46 spondylitis 9.6
47 open-angle glaucoma 9.6
48 cervicitis 9.6
49 homocysteinemia 9.6
50 malignant hypertension 9.6

Comorbidity relations with Ischemic Heart Disease via Phenotypic Disease Network (PDN): (show top 50) (show all 199)


Acquired Thrombocytopenia Active Peptic Ulcer Disease
Acute Anterolateral Myocardial Infarction Acute Apical Periodontitis
Acute Conjunctivitis Acute Cor Pulmonale
Acute Cystitis Acute Kidney Failure
Acute Myocardial Infarction Acute Myocarditis
Acute Pancreatitis Acute Stress Disorder
Adjustment Disorder Alcoholic Cardiomyopathy
Allergic Urticaria Anthracosis
Anxiety Disorder Aortic Aneurysm
Aortic Atherosclerosis Aortic Valve Disease 2
Aortic Valve Insufficiency Aplastic Anemia
Asbestosis Atrioventricular Block
Atrophic Gastritis Atypical Depressive Disorder
Autonomic Nervous System Disease Bacteremia
Basilar Artery Insufficiency Benign Essential Hypertension
Benign Hypertensive Renal Disease Benign Paroxysmal Positional Nystagmus
Benign Renovascular Hypertension Bicipital Tenosynovitis
Bleeding Disorder, Platelet-Type, 11 Blepharoconjunctivitis
Blood Platelet Disease Bronchitis
Bronchopneumonia Buerger Disease
Cardiac Arrest Cardiogenic Shock
Cardiomyopathy, Familial Hypertrophic Central Nervous System Origin Vertigo
Central Retinal Artery Occlusion Cerebral Atherosclerosis
Cerebral Degeneration Cerebrovascular Disease
Cholecystitis Chronic Kidney Failure

Graphical network of the top 20 diseases related to Ischemic Heart Disease:



Diseases related to Ischemic Heart Disease

Symptoms & Phenotypes for Ischemic Heart Disease

UMLS symptoms related to Ischemic Heart Disease:


angina pectoris, other and unspecified angina pectoris

Drugs & Therapeutics for Ischemic Heart Disease

Drugs for Ischemic Heart Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1039)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Olmesartan Approved, Investigational Phase 4,Phase 2 144689-24-7, 144689-63-4 158781 130881
2
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
4
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
5
Ranolazine Approved, Investigational Phase 4,Phase 2,Phase 3 142387-99-3, 95635-55-5 56959
6
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
7
Ticlopidine Approved Phase 4,Phase 2,Phase 3,Phase 1 55142-85-3 5472
8
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 55-56-1 9552079 2713
9
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 772 46507594
10
Tirofiban Approved Phase 4,Phase 3,Phase 2,Phase 1 144494-65-5 60947
11
Acarbose Approved, Investigational Phase 4,Phase 3 56180-94-0 441184
12
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1 79902-63-9 54454
13
Insulin Glargine Approved Phase 4,Phase 3 160337-95-1
14
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 657-24-9 14219 4091
15
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1 7440-66-6 32051 23994
16
Amlodipine Approved Phase 4,Phase 3,Phase 2 88150-42-9 2162
17
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
18
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-78-2 2244
19
Rivaroxaban Approved Phase 4,Phase 3,Phase 2 366789-02-8
20
Warfarin Approved Phase 4,Phase 2,Phase 3 81-81-2 6691 54678486
21
Chromium Approved Phase 4,Phase 2,Phase 3,Phase 1 7440-47-3 27668
22
Cilostazol Approved Phase 4,Phase 3,Phase 2 73963-72-1 2754
23
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 33069-62-4 36314
24
Rosiglitazone Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 122320-73-4 77999
25
Fluvastatin Approved Phase 4,Phase 3,Phase 2 93957-54-1 1548972
26
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
27
Ezetimibe Approved Phase 4,Phase 3,Phase 2,Phase 1 163222-33-1 150311
28
Carvedilol Approved, Investigational Phase 4,Phase 3,Phase 1 72956-09-3 2585
29
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 37350-58-6, 51384-51-1 4171
30
Coal tar Approved Phase 4,Phase 1,Phase 2 8007-45-2
31
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-61-7 60961
32
Dipyridamole Approved Phase 4,Phase 3,Phase 2,Phase 1 58-32-2 3108
33
Regadenoson Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 313348-27-5 219024
34
Nicorandil Approved Phase 4,Phase 3 65141-46-0 47528
35
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3 73590-58-6 4594
36
Pantoprazole Approved Phase 4,Phase 3,Phase 1 102625-70-7 4679
37
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-61-6, 62-31-7 681
38
Fenoldopam Approved Phase 4 67227-56-9, 67227-57-0 3341
39
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
40
Thrombin Approved Phase 4,Phase 2,Phase 3
41
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2 137862-53-4 60846
42
Menthol Approved Phase 4,Phase 3,Phase 2,Early Phase 1 2216-51-5 16666
43
Phenprocoumon Approved Phase 4 435-97-2 9908 54680692
44
Esmolol Approved Phase 4,Phase 3,Phase 1,Phase 2 103598-03-4, 81147-92-4 59768
45
Nicardipine Approved Phase 4,Early Phase 1 55985-32-5 4474
46 Trapidil Approved Phase 4 15421-84-8
47
Benzocaine Approved Phase 4,Phase 3,Phase 2,Early Phase 1 1994-09-7, 94-09-7 2337
48
Varenicline Approved, Investigational Phase 4,Phase 3,Phase 2 249296-44-4 5310966
49
Bisoprolol Approved Phase 4,Phase 2,Phase 3,Early Phase 1 66722-44-9 2405
50
Candesartan Approved Phase 4,Phase 3 139481-59-7 2541

Interventional clinical trials:

(show top 50) (show all 7064)

id Name Status NCT ID Phase Drugs
1 Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT) Unknown status NCT02360956 Phase 4 Olmesartan medoxomil tablets;Antihypertensive medication (per doctor suggestion)
2 The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease Unknown status NCT01508663 Phase 4 ARB, CCB, ACE-inhibitor, statin, Nitrate, Antiplate etc.
3 Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease Unknown status NCT00917527 Phase 4 Atorvastatin
4 Ranolazine for Improving Symptoms of Palpitations Unknown status NCT01495520 Phase 4 Ranolazine;Placebo
5 Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease Unknown status NCT02514642 Phase 4 low-dose ticagrelor;Clopidogrel
6 Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume Unknown status NCT01382277 Phase 4 Rosuvastatin
7 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4 Heart-protecting Musk Pill;Placebo
8 Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function Unknown status NCT01825759 Phase 4 danshen dripping pill
9 The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients Unknown status NCT01633359 Phase 4 Intensive statin;Routine statin
10 The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques Unknown status NCT01773512 Phase 4 Rosuvastatin
11 Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease Unknown status NCT01373632 Phase 4
12 Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease Unknown status NCT02294994 Phase 4 tirofiban
13 Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease Unknown status NCT01768585 Phase 4 Ivabradine;Placebo
14 Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa) Unknown status NCT02030054 Phase 4 Atorvastatin;Rosuvastatin
15 Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial) Unknown status NCT00858676 Phase 4 acarbose
16 Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients Unknown status NCT02001883 Phase 4 Association low-dose statin and nutraceuticals
17 Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) Unknown status NCT01035528 Phase 4 insulin glargine;metformin
18 Cerebral Artery Stenosis, Coronary Artery Disease and Arrhythmia Unknown status NCT00247533 Phase 4
19 Xience/Promus for Long Coronary Lesion Registry Unknown status NCT01147237 Phase 4
20 A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment Unknown status NCT01880879 Phase 4
21 Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity Unknown status NCT01567774 Phase 4 Atorvastatin;Rosuvastatin
22 Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients Unknown status NCT00155350 Phase 4 pioglitazone
23 Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity Unknown status NCT01490255 Phase 4 Ranolazine;Amlodipine
24 Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Unknown status NCT02334254 Phase 4 rivaroxaban and ticagrel therapy;triple antithrombotic regimen with warfarin, asipirin and clopidogrel
25 Safety and Effectiveness of the Coronary Momo Stent Unknown status NCT01535625 Phase 4
26 Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen Unknown status NCT01267734 Phase 4 Triple anti-platelet therapy (TAT);Double-dose clopidogrel anti-platelet therapy (DDAT)
27 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4 Ginkgo Biloba Extract (GBE)
28 Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus Unknown status NCT01023919 Phase 4
29 Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization Unknown status NCT01342822 Phase 4
30 Diagnostic Benefits of HyperQTM vs. Conventional ECG Stress Test. Comparison of HyperQ vs. Stress ECG in Women Before Angiography Unknown status NCT00850486 Phase 4
31 Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor Unknown status NCT01869309 Phase 4 Prasugrel;Ticagrelor
32 Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance Unknown status NCT00733174 Phase 4 Rosiglitazone;Placebo
33 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
34 Fluvastatin AmelIorates aTHerosclerosis Study Unknown status NCT01681199 Phase 4 Fluvastatin extended release tablet
35 Ranolazine, Ethnicity and the Metabolic Syndrome Unknown status NCT01304095 Phase 4 Ranolazine
36 Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents Unknown status NCT01268371 Phase 4
37 A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization Unknown status NCT01157455 Phase 4 Aspirin;Clopidogrel;Heparin or Bivalirudin
38 Periodontal Therapy in Coronary Artery Patients Unknown status NCT01609725 Phase 4
39 Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Unknown status NCT00963781 Phase 4 Reduced duration (6 months) DAPT
40 Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT Unknown status NCT01021930 Phase 4
41 Diagnostic Performance of Noninvasive Fractional Flow Reserve From Computed Tomography Unknown status NCT01747317 Phase 4
42 Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent Unknown status NCT01233453 Phase 4
43 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Unknown status NCT02004730 Phase 4
44 The Effects of Omega 3 and Vitamin E Supplementation on the Serum Antioxidant Enzymes and Gene Expressions of PGC-1a, h TERT, FOXOs and SIRTs in CAD Patients Unknown status NCT02011906 Phase 4
45 Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial Unknown status NCT01810224 Phase 4
46 Atorvastatin Plus Ezetimibe on Coronary Plaque Progression Unknown status NCT01086020 Phase 4 atorvastatin;atorvastatin plus ezetimibe
47 Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries Unknown status NCT01903902 Phase 4
48 Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty Unknown status NCT00952770 Phase 4
49 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms Unknown status NCT01776567 Phase 4
50 Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease Unknown status NCT01418794 Phase 4

Search NIH Clinical Center for Ischemic Heart Disease

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Ischemic Heart Disease cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Ischemic Heart Disease:
ACT34-CMI, bone marrow-derived cells for ischemic heart diseases
Adipocell
Adipose-derived mesenchymal stromal stem cells for ischemic heart disease
ADRCs, adipose-derived regenerative cells for cardiovascular disease
AMDC, autologous muscle-derived cells for ischemic heart failure
Autologous bone marrow-derived mesenchymal stem cells for treatment of heart muscle damage
Bone marrow-derived CD133+ stem cells for treatment of ischemic heart disease
Bone marrow-derived mesenchymal stem cells for treatment of heart diseases
Bone marrow-derived mesenchymal stem cells for treatment of ischemic cardiomyopathy
Bone marrow-derived mesenchymal stem cells for treatment of ischemic cardiomyopathy during artery bypass grafting
Bone marrow-derived mesenchymal stem cells for treatment of ischemic heart disease
Bone marrow-derived mononuclear cells for ischemic cardiomyopathy
Bone marrow-derived mononucleated cells for heart disease
Bone marrow-derived stem cells for treatment of chronic ischemic heart failure
Bone marrow-derived stem cells for treatment of ischemic cardiomyopathy
Bone marrow-derived stem cells for treatment of severe chronic ischemic heart disease
Cardiac stem cells for treatment of ischemic cardiomyopathy
Cardiocell
Combination therapy of mononuclear cells with laser for coronary disease
Embryonic stem cell-derived cardiomyocytes for ischemic myocardium
Enriched bone marrow-derived progenitor cells for heart diseases
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Mesendo, stem cell combination for treatment of cardiovascular diseases
Peripheral mononuclear cells CD34+ stem cells for treatment of myocardial ischemia
Peripheral or bone marrow-derived stem cells for chronic heart failure
StempeucelICM
Embryonic/Adult Cultured Cells Related to Ischemic Heart Disease:
Bone marrow-derived CD34+ stem cells (ACT34) PMIDs: 11283669 12551872 22163120 20448213 9020076 17562958 21737787
VEGF-A165-stimulated ADSCs
Adipose-derived stem and regenerative cells PMIDs: 21082397 22281257
Autologous muscle-derived cells
Bone marrow-derived mesenchymal stem cells (family) PMIDs: 21052537 19591227
Bone marrow-derived CD133+ cells
Bone marrow-derived mesenchymal stem cells PMIDs: 22940024 21392602
Bone marrow-derived hematopoietic stem cells (family)
Bone marrow-derived stem cells
Bone marrow-derived mononuclear cells (family) PMIDs: 21392602 22940024
Porcine bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024
Human cardiac stem cells PMIDs: 22088800 22965994
Cardiomyocyte-like cells PMIDs: 18941512
Bone marrow-derived progenitor cells PMIDs: 23362308 22936827 18794392 16990384 16990385 22651868
Bone marrow-derived mononuclear cells PMIDs: 21323410 20631864
Bone marrow-derived mesenchymal stem cells PMIDs: 21323410 20631864
Peripheral blood-derived hematopoietic stem cells (family)
Bone marrow-derived mononuclear cells PMIDs: 20668107 21596713 19761394 22834565
Bone marrow-derived mesenchymal stem cells (Stempeucel PMIDs: 18720444

Genetic Tests for Ischemic Heart Disease

Anatomical Context for Ischemic Heart Disease

MalaCards organs/tissues related to Ischemic Heart Disease:

39
Heart, Endothelial, Bone, Testes, Kidney, Bone Marrow, Breast
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Ischemic Heart Disease:
id Tissue Anatomical CompartmentCell Relevance
1 Limb Pelvic Girdle Bone Marrow Stromal Cells Potential therapeutic candidate
2 Bone Bone Marrow Bone Marrow Stromal Cells Potential therapeutic candidate

Publications for Ischemic Heart Disease

Articles related to Ischemic Heart Disease:

(show top 50) (show all 971)
id Title Authors Year
1
Small airway dysfunction in smokers with stable ischemic heart disease. ( 28846677 )
2017
2
Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial. ( 28903941 )
2017
3
Thyroid function and ischemic heart disease: a Mendelian randomization study. ( 28819171 )
2017
4
Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease. ( 27911047 )
2017
5
Estimation of Antioxidant Levels in Saliva and Serum of Chronic Periodontitis Patients with and without Ischemic Heart Disease. ( 28781595 )
2017
6
Tumor necrosis factor-alpha gene polymorphisms and susceptibility to ischemic heart disease: A systematic review and meta-analysis. ( 28383437 )
2017
7
Myofilament remodeling and function is more impaired in peripartum cardiomyopathy compared to dilated cardiomyopathy and ischemic heart disease. ( 28935576 )
2017
8
Self-Rated Health Status and Risk of Ischemic Heart Disease in the China Kadoorie Biobank Study: A Population-Based Cohort Study. ( 28939702 )
2017
9
Selective Pressure-Regulated Retroinfusion for Gene Therapy Application in Ischemic Heart Disease. ( 27910055 )
2017
10
The Effects of Age, Period, and Cohort on Mortality from Ischemic Heart Disease in China. ( 28067846 )
2017
11
Cardioprotective Effects of Pomegranate (Punica granatum) Juice in Patients with Ischemic Heart Disease. ( 28913846 )
2017
12
Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study. ( 28880460 )
2017
13
Epidemiology of ischemic heart disease in HIV. ( 28799997 )
2017
14
Circadian Periodicity of Ischemic Heart Disease: A Systematic Review of the Literature. ( 28865776 )
2017
15
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study. ( 28862961 )
2017
16
HIV and Ischemic Heart Disease. ( 28057253 )
2017
17
Influence of the amount of myocardium subtended to a coronary stenosis on the index of microcirculatory resistance. Implications for the invasive assessment of microcirculatory function in ischemic heart disease. ( 28485281 )
2017
18
A Case of Subclavian Artery Aneurysm with History of Ischemic Heart Disease Operated Under Cervical Epidural Anesthesia. ( 28298800 )
2017
19
Spinal cord infarction mimicking ischemic heart disease. ( 28717781 )
2017
20
Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques. ( 28916844 )
2017
21
The long-term risk of smoking in diabetic patients with stable ischemic heart disease treated with intensive medical therapy and lifestyle modification. ( 28517955 )
2017
22
Left ventricular diastolic dysfunction in women with nonobstructive ischemic heart disease: insights from magnetic resonance imaging and spectroscopy. ( 28794105 )
2017
23
Impact of diabetes on heart failure incidence in adults with ischemic heart disease. ( 28947278 )
2017
24
The Association Between Giant Cell Arteritis and Ischemic Heart Disease: A Population Based Cross-Sectional Study. ( 28786254 )
2017
25
Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease. ( 28709768 )
2017
26
Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve. ( 28813561 )
2017
27
Gugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice. ( 28910310 )
2017
28
Mental stress-induced left ventricular dysfunction and adverse outcome in ischemic heart disease patients. ( 28067532 )
2017
29
Guidelines in review: ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. ( 28836156 )
2017
30
Seasonal Periodicity of Ischemic Heart Disease and Heart Failure. ( 28865777 )
2017
31
Differential proteome profile in ischemic heart disease: Prognostic value in chronic angina versus myocardial infarction. A proof of concept. ( 28501389 )
2017
32
MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease. ( 28865712 )
2017
33
Hidden in Plain Sight: Lung Impairment in Ischemic Heart Disease. ( 27585376 )
2016
34
Experiences of peer support in self-management interventions among people with ischemic heart disease: a systematic review protocol. ( 27532134 )
2016
35
Concomitant CABG, Left Ventricular Restoration and Mitral Valve Repair for Ischemic Heart Disease. ( 28054895 )
2016
36
The Role of Influenza in the Delay between Low Temperature and Ischemic Heart Disease: Evidence from Simulation and Mortality Data from Japan. ( 27136571 )
2016
37
Correction to: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guidelineon Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. ( 27601566 )
2016
38
Interactive effects of obesity and physical fitness on risk of ischemic heart disease. ( 27867205 )
2016
39
The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona. ( 27169692 )
2016
40
Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population. ( 26761769 )
2016
41
Association of interleukin-6 methylation in leukocyte DNA with serum level and the risk of ischemic heart disease. ( 26986049 )
2016
42
Association between Noise Pollution and Prevalent Ischemic Heart Disease. ( 28068283 )
2016
43
Intramyocardial Dissecting Hematoma: Cardiac Trauma and Ischemic Heart Disease: Multimodality Imaging Techniques. ( 27112500 )
2016
44
Cardiovascular Risk Factors and Ischemic Heart Disease: Is the Confluence of Risk Factors Greater than the Parts? A Genetic Approach. ( 27103211 )
2016
45
Association of Patient Beliefs and Preferences With Subsequent Testing After Initial Evaluation for Ischemic Heart Disease. ( 28017386 )
2016
46
Association of Major Depression With Risk of Ischemic Heart Disease in a Mega-Cohort of Chinese Adults: The China Kadoorie Biobank Study. ( 28003250 )
2016
47
Effect of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: A Mendelian randomization study. ( 27914500 )
2016
48
Occupational noise and ischemic heart disease: A systematic review. ( 27569404 )
2016
49
Spatial Patterns of Ischemic Heart Disease in Shenzhen, China: A Bayesian Multi-Disease Modelling Approach to Inform Health Planning Policies. ( 27104551 )
2016
50
The Role of MicroRNA and LncRNA-MicroRNA Interactions in Regulating Ischemic Heart Disease. ( 27635038 )
2016

Variations for Ischemic Heart Disease

ClinVar genetic disease variations for Ischemic Heart Disease:

6
id Gene Variation Type Significance SNP ID Assembly Location
1 NOS3 NM_000603.4(NOS3): c.894T> G (p.Asp298Glu) single nucleotide variant risk factor rs1799983 GRCh37 Chromosome 7, 150696111: 150696111

Expression for Ischemic Heart Disease

LifeMap Discovery
Genes differentially expressed in tissues of Ischemic Heart Disease patients vs. healthy controls: 35
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1 EIF1AY eukaryotic translation initiation factor 1A, Y-linked Heart + 3.61 0.020
2 LEP leptin Heart + 3.55 0.003
3 MFSD4 major facilitator superfamily domain containing 4 Endothelium + 3.54 0.000
4 FOSB FBJ murine osteosarcoma viral oncogene homolog B Heart + 3.13 0.012
5 DDX3Y DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked Heart + 3.12 0.017
6 RBP4 retinol binding protein 4, plasma Heart + 3.11 0.011
Search GEO for disease gene expression data for Ischemic Heart Disease.

Pathways for Ischemic Heart Disease

GO Terms for Ischemic Heart Disease

Sources for Ischemic Heart Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....